<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: To correlate known <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> risk factors and the signs of extracranial and intracranial changes of vascular origin in young patients with heterozygous familial <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo> (FH) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: 39 DNA test-verified heterozygous FH North Karelian patients (FH-NK), aged 6 to 48, 28 of them treated with <z:chebi fb="0" ids="35664">statins</z:chebi>, and 25 healthy controls underwent brain magnetic resonance imaging (MRI) and carotid ultrasound </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Common carotid intima-media thickness was significantly greater in the patients (P=0.005) </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> angiography showed no pathological changes, other than 1 incidental <z:hpo ids='HP_0002617'>aneurysm</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The number and size of white matter hyperintensities on T2-weighted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> images, considered as markers of microvascular alterations, did not differ between patients and controls </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: FH-NK patients treated with <z:chebi fb="0" ids="35664">statins</z:chebi> seem to be at no increased risk for brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> or other <z:e sem="disease" ids="C0221505" disease_type="Disease or Syndrome" abbrv="">brain lesions</z:e> of vascular origin when younger than age 50 </plain></SENT>
</text></document>